d and d drug realty company LLC

21-51 42nd street
astoria, new york 11105

NYS Entity Status
ACTIVE

NYS Filing Date
FEBRUARY 11, 2014

NYS DOS ID#
4527400

County
QUEENS

Jurisdiction
DELAWARE

Registered Agent
NONE

NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY

Name History
2014 - D AND D DRUG REALTY COMPANY LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Hungry City: In Queens, Star Treatment for Seafood
    By LIGAYA MISHAN - Thursday Nov 16, 2017

    AbuQir in the Little Egypt section of Astoria lets you pick your fish and how it is prepared.

    Source: NYT > Home Page
  • What Does It Cost to Create a Cancer Drug? Less Than You’d Think
    By GINA KOLATA - Monday Sep 11, 2017

    A new study suggests that biotech companies are spending far less than believed on research and development for approved drugs, despite rising prices.

    Source: NYT > Home Page
  • Coffee recalled for containing Viagra-like ingredient
    By Fox News - Thursday Jul 20, 2017

    A company based in Texas has recalled a coffee product after a substance found in a drug used to treat erectile dysfunction was found in the product, the Food and Drug Administration (FDA) confirmed. Bestherbs Coffee LLC has recalled all of its “New of Kopi Jantan Tradisional Herbs Coffee” after the FDA said it found...

    Source: New York Post: News
  • Impax Laboratories and Amneal Pharmaceuticals Near Merger Agreement
    Monday Oct 16, 2017

    Impax Laboratories Inc. and Amneal Pharmaceuticals LLC are close to agreement on a merger that would create the nation’s fifth-largest generic-drug company by revenue, according to people familiar with the matter.

    Source: The Wall Street Journal: U.S. Business
  • California passes prescription drug pricing transparency bill
    By Catherine Ho - Thursday Sep 14, 2017

    State legislators have passed a bill aimed at creating greater transparency around prescription drug pricing by requiring pharmaceutical manufacturers to provide advance notice and more detailed explanations for raising the price of a drug. The bill, co-authored by Assemblyman David Chiu (D-San Francisco) and Sen. Ed Hernandez (D-West Covina), was approved by the Senate on Wednesday after clearing the Assembly earlier this week. The proposal now heads to Gov. Jerry Brown. Under the legislation, SB 17, drug companies would have to alert health insurers at least 60 days before they plan to increase the price of a drug if the increase is at least 16 percent over a two-year period.

    Source: SFGATE.com: Business and Technology News
  • New York company ID'd as maker of Arkansas execution drug
    By KELLY P. KISSEL and ANDREW DeMILLO, Associated Press - Wednesday Nov 8, 2017

    LITTLE ROCK, Ark. (AP) — Arkansas has identified a New York pharmaceutical company as the maker of one of its lethal injection drugs, and the company says it doesn't want any of its products used in executions.A package insert for the state's supply of midazolam released by the state Wednesday identifies Athenex as the maker of the drug, one of three used in Arkansas' lethal injection process. The insert was included as part of an affidavit filed by state Correction Department officials.Athenex did not immediately reply to a request for comment.

    Source: SFGATE.com: Top News Stories